000559:SZSEWanxiang Qianchao Co.,Ltd. Analysis
Data as of 2026-03-17 - not real-time
CN¥16.53
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Wanxiang Qianchao is trading at CNY 16.53, just above the computed support of CNY 16.51 and well below its 20‑day SMA of 18.51, while the 200‑day SMA sits at 11.80, indicating a longer‑term bullish backdrop. However, the MACD histogram is negative, the RSI sits at 39.9, and volume is on a decreasing trend, all pointing to short‑term weakness amid a 30‑day volatility of roughly 59% and a low beta of 0.41.
On the fundamentals side, revenue grew 15.7% YoY with modest margins (gross 16%, operating 12.5%), but the stock commands a lofty PE of 53 versus a DCF‑derived fair value of about CNY 10.10, suggesting it is overvalued by roughly 39%. The dividend yield of 1.08% is supported by a 58.8% payout ratio and solid cash generation, and the lone analyst rating is a "strong buy" despite the valuation pressure.
On the fundamentals side, revenue grew 15.7% YoY with modest margins (gross 16%, operating 12.5%), but the stock commands a lofty PE of 53 versus a DCF‑derived fair value of about CNY 10.10, suggesting it is overvalued by roughly 39%. The dividend yield of 1.08% is supported by a 58.8% payout ratio and solid cash generation, and the lone analyst rating is a "strong buy" despite the valuation pressure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above support level
- Bearish MACD histogram and neutral RSI
- Decreasing trading volume indicating waning momentum
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong 15% revenue growth but high PE valuation
- Stable cash flow and sustainable dividend payout
- Potential valuation correction as price exceeds DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent top‑line growth in the auto‑parts cycle
- Low beta and solid cash reserves mitigate downside risk
- Attractive dividend yield with a manageable payout ratio
Key Metrics & Analysis
Financial Health
Revenue Growth15.70%
Profit Margin7.26%
P/E Ratio53.3
ROE10.73%
ROA2.97%
Debt/Equity70.70
P/B Ratio5.8
Op. Cash FlowCN¥1.9B
Free Cash FlowCN¥1.2B
Technical Analysis
TrendBullish
RSI39.9
SupportCN¥16.51
ResistanceCN¥20.88
MA 20CN¥18.51
MA 50CN¥18.10
MA 200CN¥11.80
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45
Valuation
Fair ValueCN¥10.10
Target PriceCN¥23.00
Upside/Downside39.14%
GradeOvervalued
TypeGrowth
Dividend Yield1.08%
Risk Assessment
Beta0.41
Volatility59.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.